SSRI adverse events: How to monitor and manage

References

• Baumer FM, Howe M, Gallelli K, Simeonova DI, Hallmayer J, Chang KD. A pilot study of antidepressant-induced mania in pediatric bipolar disorder: Characteristics, risk factors, and the serotonin transporter gene. Biological Psychiatry 2006; 60(9)1005–1012
   PubMedGoogle Scholar
• Bridge JA, Iyengar S, Salary CB, Barbe RP, Birmaher B, Pincus HA, et al. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: A meta-analysis of randomized controlled trials. Journal of the American Medical Association 2007; 297(15)1683–1696
   PubMed Web of Science ®Google Scholar
• Brosen K. Some aspects of genetic polymorphism in the biotransformation of antidepressants. Therapie 2004; 59(1)5–12
   PubMed Web of Science ®Google Scholar
• Carlson GA. Early onset bipolar disorder: Clinical and research considerations. Journal of Clinical Child Adolescent Psychology 2005; 34(2)333–343
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Suicide trends among youths and young adults aged 10–24 years–United States, 1990–2004. 2007; 56(35)905–908, MMWR Morb Mortal Wkly Rep. Sep 7
   Google Scholar
• Cheung AH, Emslie GJ, Mayes TL. Review of the efficacy and safety of antidepressants in youth depression. Journal of Child Psychology and Psychiatry 2005; 46(7)735–754
   PubMed Web of Science ®Google Scholar
• Craney J, Geller B. Clinical implications of antidepressant and stimulant use on switching from depression to mania in children. Journal of Child Adolescent Psychopharmacology 2003; 13(2)201–204
   PubMedGoogle Scholar
• Faedda GL, Baldessarini RJ, Glovinsky IP, Austin NB. Treatment-emergent mania in pediatric bipolar disorder: A retrospective case review. Journal of Affective Disorders 2004; 82(1)149–158
   PubMedGoogle Scholar
• Garland EJ, Baerg EA. Amotivational syndrome associated with selective serotonin reuptake inhibitors in children and adolescents. Journal of Child Adolescent Psychopharmacology 2001; 11(2)181–186
   PubMed Web of Science ®Google Scholar
• Gibbons RD, Brown CH, Hur K, Marcus SM, Bhaumik DK, Erkens JA, Herings RM, Mann JJ. Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents. American Journal of Psychiatry 2007; 164(9)1356–1363
   PubMed Web of Science ®Google Scholar
• Go FS, Malley EE, Birmaher B, Rosenberg DR. Manic behaviors associated with fluoxetine in three 12- to 18-year-olds with obsessive-compulsive disorder. Journal of Child Adolescent Psychopharmacology 1998; 8(1)73–80
   PubMed Web of Science ®Google Scholar
• Goodman WK, Murphy TK, Storch EA. Risk of adverse behavioral effects with pediatric use of antidepressants. Psychopharmacology (Berl) 2007; 191(1)87–96
   PubMed Web of Science ®Google Scholar
• Gross C, Zhuang X, Stark K, Ramboz S, Oosting R, Kirby L, et al. Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature 2002; 416(6879)396–400
   PubMed Web of Science ®Google Scholar
• Guile JM. Sertraline-induced behavioral activation during the treatment of an adolescent with major depression. Journal of Child Adolescent Psychopharmacology 1996; 6(4)281–285
   PubMed Web of Science ®Google Scholar
• Halperin D, Reber G. Influence of antidepressants on hemostasis. Dialogues of Clinical Neuroscience 2007; 9(1)47–59
   PubMedGoogle Scholar
• Hammad TA, Laughren T, Racoosin J. Suicidality in pediatric patients treated with antidepressant drugs. Archives of General Psychiatry 2006; 63(3)332–339
   PubMed Web of Science ®Google Scholar
• Herguner S, Kilincaslan A, Gorker I, Tuzun U. Serotonin-selective reuptake inhibitor-induced enuresis in three pediatric cases. Journal of Child Adolescent Psychopharmacology 2007; 17(3)367–369
   PubMedGoogle Scholar
• Jick H, Kaye JA, Jick SS. Antidepressants and the risk of suicidal behaviors. Journal of the American Medical Association 2004; 292(3)338–343
   PubMed Web of Science ®Google Scholar
• Kowatch RA, Youngstrom EA, Danielyan A, Findling RL. Review and meta-analysis of the phenomenology and clinical characteristics of mania in children and adolescents. Bipolar Disorder 2005; 7(6)483–496
   PubMed Web of Science ®Google Scholar
• Laje G, Paddock S, Manji H, Rush AJ, Wilson AF, Charney D, et al. Genetic markers of suicidal ideation emerging during citalopram treatment of major depression. American Journal of Psychiatry 2007; 164(10)1530–1538
   PubMedGoogle Scholar
• Lake MB, Birmaher B, Wassick S, Mathos K, Yelovich AK. Bleeding and selective serotonin reuptake inhibitors in childhood and adolescence. Journal of Child Adolescent Psychopharmacology 2000; 10(1)35–38
   PubMed Web of Science ®Google Scholar
• Leon AC, Marzuk PM, Tardiff K, Bucciarelli A, Markham Piper T, Galea S. Antidepressants and youth suicide in New York City, 1999–2002. Journal of the American Academy of Child Adolescent Psychiatry 2006; 45: 1054–1058
   PubMedGoogle Scholar
• Libby AM, Brent DA, Morrato EH, Orton HD, Allen R, Valuck RJ. Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs. American Journal of Psychiatry 2007; 164(6)884–891
   PubMed Web of Science ®Google Scholar
• Manassis K. When attention-deficit/hyperactivity disorder co-occurs with anxiety disorders: Effects on treatment. Expert Review Neurotherapeutics 2007; 7(8)981–988
   PubMedGoogle Scholar
• March JS, Klee BJ, Kremer CM. Treatment benefit and the risk of suicidality in multicenter, randomized, controlled trials of sertraline in children and adolescents. Journal of Child Adolescent Psychopharmacology 2006; 16(1–2)91–102
   PubMedGoogle Scholar
• MHRA. Committee on Safety of Medicines, Expert Group on Safety of SSRIs: Minutes. June 20, 2003, 2003. http://www.mhra.gov.uk/home/groups/plp/documents/committeedocument/con003485.pdf. Accessed November 30, 2005
   Google Scholar
• Nemeroff CB, Kalali A, Keller MB, Charney DS, Lenderts SE, Cascade EF, et al. Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States. Archives General Psychiatry 2007; 64(4)466–472
   PubMedGoogle Scholar
• Olfson M, Shaffer D, Marcus SC, Greenberg T. Relationship between antidepressant medication treatment and suicide in adolescents. Archives General Psychiatry 2003; 60(10)978–982
   PubMed Web of Science ®Google Scholar
• Perlis RH, Mischoulon D, Smoller JW, Wan YJ, Lamon-Fava S, Lin KM, et al. Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment. Biological Psychiatry 2003; 54(9)879–883
   PubMedGoogle Scholar
• Reinblatt SP, Riddle MA. Selective serotonin reuptake inhibitor-induced apathy: A pediatric case series. Journal of Child Adolescent Psychopharmacology 2006; 16(1–2)227–233
   PubMedGoogle Scholar
• Riddle MA, King RA, Hardin MT, Scahill L, Ort SI, Leckman JF. Behavioral side effects of fluoxetine in children and adolescents. Journal of Child and Adolescent Psychopharmacology 1991; 1: 193–198
   Google Scholar
• Safer DJ, Zito JM. Treatment-emergent adverse events from selective serotonin reuptake inhibitors by age group: Children versus adolescents. Journal of Child Adolescent Psychopharmacology 2006; 16(1–2)159–169
   PubMed Web of Science ®Google Scholar
• Scharko AM. Selective serotonin reuptake inhibitor-induced sexual dysfunction in adolescents: A review. Journal of the American Academy of Child Adolescent Psychiatry 2004; 43(9)1071–1079
   PubMedGoogle Scholar
• Walkup J, Labellarte M. Complications of SSRI treatment. Journal of Child Adolescent Psychopharmacology 2001; 11(1)1–4
   PubMed Web of Science ®Google Scholar
• Weintrob N, Cohen D, Klipper-Aurbach Y, Zadik Z, Dickerman Z. Decreased growth during therapy with selective serotonin reuptake inhibitors. Archives of Pediatric and Adolescent Medicine 2002; 156(7)696–701
   PubMedGoogle Scholar
• Weller EB, Weller RA, Kloos AL, Hitchcock S, Kim WJ, Zemel B. Impact of depression and its treatment on the bones of growing children. Current Psychiatry Report 2007; 9(2)94–98
   PubMedGoogle Scholar
• Wilens TE, Biederman J, Kwon A, Chase R, Greenberg L, Mick E, et al. A systematic chart review of the nature of psychiatric adverse events in children and adolescents treated with selective serotonin reuptake inhibitors. Journal of Child Adolescent Psychopharmacology 2003; 13(2)143–152
   PubMed Web of Science ®Google Scholar